Joi Ennis, NP
Women's Health · Elizabeth, NJNPI 1205341658
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. 2024 is the largest year on record at $91, 2.5 times the $36 reported in 2021. That places this record below the midpoint for women's health clinicians in NJ, where the typical reported total is $266.
Across 14 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$47
- Convatec Inc.$31
- Daiichi Sankyo Inc.$29
- Organon$22
- Roche Diagnostics Corporation$22
- Astellas Pharma US Inc$22
- plus $75 from 5 others
What the payments were for
- Food & beverage$248100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 3 | $47 |
| Convatec Inc. | 1 | $31 |
| Daiichi Sankyo Inc. | 2 | $29 |
| Organon | 1 | $22 |
| Roche Diagnostics Corporation | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Pfizer | 1 | $15 |
| Merck | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
How this compares
$248 in reported general payments places this provider in the 45th percentile of 182 women's health providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 13 | $288 |
| Nystatin | 21 | $158 |
| Junel FeNorethindrone-E.Estradiol-Iron | 21 | $96 |
| ValacyclovirValacyclovir Hcl | 11 | $76 |
Paid to pharmacies, not to this prescriber.
Other women's health in Elizabeth
- Kathie OlsonLawrenceville$5K
- Valerie FultonPennsauken$5K
- Patience AssobmoNewark$5K
- Lorraine HarrisPennsauken$4K
- Edita LuansingRidgewood$4K
- Seton CiagliaOradell$3K
- Kelsey DenningToms River$3K
- Alyssa DallicardilloBarnegat$3K
- Marisa Buonanno-HamrahWest Orange$2K
- Michelle GavalaSpringfield$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.